Skip to content
Gene2Rx home

Try

Loading…

Search couldn't load. Check your connection and try again, or use the medication lookup.

No pages match .

The medication lookup checks any medication by name, including ones without their own page.

Get my report

Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report

Cholesterol medicationsExample report

Pravastatin

Pravachol

Use with caution

Your body may process this drug more slowly, so higher doses might carry added risks.

The genes behind this label

The guidelines read one gene for pravastatin. Each card shows the two copies this person inherited and what they mean.

SLCO1B1Your two copies: *15/*1A

Decreased function

One copy works and one works less well.

Moves statins into the liver.

This result changes the label.

What the guidelines say

What each guideline says about your result.

SLCO1B1Decreased function

In plain words
Your body may process this drug more slowly, so higher doses might carry added risks.
What it means
Increased pravastatin exposure compared with normal function; typical myopathy risk with doses ≤40 mg
What the guideline suggests
Prescribe desired starting dose and adjust doses of pravastatin based on disease-specific guidelines. Prescriber should be aware of possible increased risk for myopathy especially with doses >40 mg per day.

About pravastatin

Pravastatin (Pravachol) is a statin that lowers LDL cholesterol and the risk of heart attack and stroke.

Used for
Lowering LDL cholesterol in adults, and in children 8 and older with familial hypercholesterolemia; reducing heart attack, stroke, artery-opening procedures and cardiovascular death in adults with or without known coronary heart disease

Read more about pravastatin and genetics

Others in cholesterol medications

Compare all 7 cholesterol medications

Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.

Back to the example report